Neurosense Therapeutics (NRSN) Releases Letter to Shareholders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil slips from five-month highs with Hormuz crossings, Russian sanctions waiver in focus
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| (NASDAQ: NRSN) | Delayed: 2.49 -0.58 (18.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.07 | 52 Week High | $ | |||
| Open | $2.94 | 52 Week Low | $ | |||
| Day High | $2.94 | P/E | N/A | |||
| Day Low | $2.44 | EPS | $ | |||
| Volume | 85,855 | |||||
